I guess it depends on what you believe all the way means. If you're indicating through to first approval ie clarify, I'm sceptical there is enough cash to get us into 2027. We will have another trial in DX BCR to fund as well.
will it be enough to get us through to an acquisition with enough cash leverage? I think this is likely.
My forecast is they'll have enough for 2-2.5yrs using 15-20m quarter spend. But hopefully P2 readouts(or interim for confidential players) will be available, clarify readouts also available with probable positive, which will put us in a strong position.
Ann: Clarity launches $121 million equity raise, page-31
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.46 |
Change
0.090(1.41%) |
Mkt cap ! $2.013B | |||
| Open | High | Low | Value | Volume |
| $6.40 | $6.50 | $6.13 | $10.02M | 1.580M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3329 | $6.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.50 | 45351 | 7 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |